| Financial Year |
March 31 2023 |
| Monetary Funds |
311,217,505.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,348,705,001.20 |
| Advances to Suppliers |
88,510,564.98 |
| Other Receivables |
28,118,457.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
6,942.42 |
| Inventories |
724,121,683.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,527,810.61 |
| Total Current Assets |
2,611,580,647.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
115,238,482.58 |
| Fixed Assetes |
1,067,325,819.59 |
| Under-construction Projects |
46,721,437.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
218,961,597.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
52,457,139.66 |
| Other Non-Current Assets |
22,134,127.74 |
| Sub-Total of Non-Current Assets |
1,529,460,818.46 |
| Total Assets |
4,141,041,465.66 |
| Short-Term Loans |
235,072,236.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
161,622,266.00 |
| Accounts Payable |
642,353,915.19 |
| Accounts Received In Advance |
1,687,260.84 |
| Employee Compensation Payable |
7,055,124.38 |
| Taxes Payable |
22,660,186.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,283,988.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,191,619.38 |
| Other Current Liabilities |
1,236,659.44 |
| Sub-Total of Current Liabilities |
1,165,481,991.11 |
| Long-term Loans |
20,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
69,517,826.13 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,257,701.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
380,272,068.70 |
| Total Liabilities |
1,545,754,059.81 |
| Paid-In Capital(Or Share Stock) |
724,228,400.00 |
| Capital Surplus |
722,338,545.56 |
| Surplus Reserve |
26,564,764.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,026,461,730.37 |
| Minority Stockholder's Interest |
15,459,201.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,579,828,204.47 |
| Owner's Equity（Stockholder's Equity） |
2,595,287,405.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,141,041,465.66 |
